Comparative Study
doi: 10.1097/01.inf.0000130075.56368.02.
Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002
Affiliations
- PMID: 15194842
- DOI: 10.1097/01.inf.0000130075.56368.02
Item in Clipboard
Comparative Study
Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002
Pediatr Infect Dis J.
2004 Jun.
Abstract
To assess whether pertussis-containing vaccines cause encephalitis or encephalopathy, the IMPACT network of Canadian pediatric centers screened more than 12,000 admissions for neurologic disorders between 1993 and 2002. Seven cases of encephalopathy began within 7 days after pertussis vaccination, but a more likely cause was found in each instance. No attributable case followed administration of >6.5 million doses of vaccine.
Similar articles
-
Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.Pediatr Int. 2004 Dec;46(6):650-5. doi: 10.1111/j.1442-200x.2004.01970.x. Pediatr Int. 2004. PMID: 15660862
-
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.Pediatr Infect Dis J. 2007 Jan;26(1):31-5. doi: 10.1097/01.inf.0000247055.81541.04. Pediatr Infect Dis J. 2007. PMID: 17195702
-
Lack of association between childhood immunizations and encephalitis in California, 1998-2008.Vaccine. 2012 Jan 5;30(2):247-53. doi: 10.1016/j.vaccine.2011.10.104. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22080172
-
National consensus conference on pertussis, Toronto, May 25-28, 2002.Can Commun Dis Rep. 2003 Apr;29 Suppl 3:1-33 (Eng), 1-36 (Fre). Can Commun Dis Rep. 2003. PMID: 14558307 Review. English, French. No abstract available.
-
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.Vaccine. 2013 Oct 25;31(45):5178-91. doi: 10.1016/j.vaccine.2013.08.034. Epub 2013 Aug 28. Vaccine. 2013. PMID: 23994021 Review.
Cited by
-
The potential neurological effect of the COVID-19 vaccines: A review.Acta Neurol Scand. 2021 Jul;144(1):3-12. doi: 10.1111/ane.13417. Epub 2021 Mar 29. Acta Neurol Scand. 2021. PMID: 33779985 Free PMC article. Review.
-
Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.J Med Internet Res. 2020 Jun 1;22(6):e17446. doi: 10.2196/17446. J Med Internet Res. 2020. PMID: 32234696 Free PMC article.
-
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.Pediatrics. 2018 Jul;142(1):e20174171. doi: 10.1542/peds.2017-4171. Epub 2018 Jun 4. Pediatrics. 2018. PMID: 29866795 Free PMC article.
-
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1. MMWR Recomm Rep. 2018. PMID: 29702631 Free PMC article.
-
IMPACT after 17 years: Lessons learned about successful networking.Can J Infect Dis Med Microbiol. 2009 Spring;20(1):12-4. Can J Infect Dis Med Microbiol. 2009. PMID: 20190889 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
